메뉴 건너뛰기




Volumn 73, Issue 2, 2012, Pages 212-214

Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus

Author keywords

Staphylococcus sciuri; Teicoplanin; Vancomycin

Indexed keywords

ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; GLYCOPEPTIDE; LINEZOLID; OXACILLIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

EID: 84861138590     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.02.005     Document Type: Article
Times cited : (23)

References (20)
  • 1
    • 80054774222 scopus 로고    scopus 로고
    • Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades
    • Ahlstrand E., Svensson K., Persson L., Tidefelt U., Soderquist B. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. Eur J Clin Microbiol Infect Dis 2011, 30:1349-1354.
    • (2011) Eur J Clin Microbiol Infect Dis , vol.30 , pp. 1349-1354
    • Ahlstrand, E.1    Svensson, K.2    Persson, L.3    Tidefelt, U.4    Soderquist, B.5
  • 2
    • 2942665465 scopus 로고    scopus 로고
    • The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
    • Arbeit R.D., Maki D., Tally F.P., Campanaro E., Eisenstein B.I. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004, 38:1673-1681.
    • (2004) Clin Infect Dis , vol.38 , pp. 1673-1681
    • Arbeit, R.D.1    Maki, D.2    Tally, F.P.3    Campanaro, E.4    Eisenstein, B.I.5
  • 7
    • 77950508075 scopus 로고    scopus 로고
    • Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections
    • Cremniter J., Slassi A., Quincampoix J.C., Sivadon-Tardy V., Bauer T., Porcher R., et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol 2010, 48:1428-1431.
    • (2010) J Clin Microbiol , vol.48 , pp. 1428-1431
    • Cremniter, J.1    Slassi, A.2    Quincampoix, J.C.3    Sivadon-Tardy, V.4    Bauer, T.5    Porcher, R.6
  • 8
    • 84872214848 scopus 로고    scopus 로고
    • Cubist Pharmaceuticals, Inc., Lexington (Mass), Available at:, Accessed January 1, 2012
    • Cubicin Package Insert 2009, Cubist Pharmaceuticals, Inc., Lexington (Mass), Available at:, Accessed January 1, 2012. http://www.cubicin.com/pdf/PrescribingInformation.pdf.
    • (2009) Cubicin Package Insert
  • 10
    • 33747365321 scopus 로고    scopus 로고
    • Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    • Fowler V.G., Boucher H.W., Corey G.R., Abrutyn E., Karchmer A.W., Rupp M.E., et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006, 355:653-665.
    • (2006) N Engl J Med , vol.355 , pp. 653-665
    • Fowler, V.G.1    Boucher, H.W.2    Corey, G.R.3    Abrutyn, E.4    Karchmer, A.W.5    Rupp, M.E.6
  • 11
    • 79957597382 scopus 로고    scopus 로고
    • High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study
    • Kullar R., Davis S.L., Levine D.P., Zhao J.J., Crank C.W., Segreti J., et al. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy 2011, 31:527-536.
    • (2011) Pharmacotherapy , vol.31 , pp. 527-536
    • Kullar, R.1    Davis, S.L.2    Levine, D.P.3    Zhao, J.J.4    Crank, C.W.5    Segreti, J.6
  • 12
    • 55449097582 scopus 로고    scopus 로고
    • Clinical experience with daptomycin: bacteraemia and endocarditis
    • Levine D.P. Clinical experience with daptomycin: bacteraemia and endocarditis. JAntimicrob Chemother 2008, 62(Suppl 3):iii35-iii39.
    • (2008) JAntimicrob Chemother , vol.62 , Issue.SUPPL. 3
    • Levine, D.P.1
  • 13
    • 67649871211 scopus 로고    scopus 로고
    • Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options
    • Natoli S., Fontana C., Favaro M., Bergamini A., Testore G.P., Minelli S., et al. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infect Dis 2009, 9:83.
    • (2009) BMC Infect Dis , vol.9 , pp. 83
    • Natoli, S.1    Fontana, C.2    Favaro, M.3    Bergamini, A.4    Testore, G.P.5    Minelli, S.6
  • 14
    • 0023135918 scopus 로고
    • Emergence of vancomycin resistance in coagulase-negative staphylococci
    • Schwalbe R.S., Stapleton J.T., Gilligan P.H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987, 316:927-931.
    • (1987) N Engl J Med , vol.316 , pp. 927-931
    • Schwalbe, R.S.1    Stapleton, J.T.2    Gilligan, P.H.3
  • 15
    • 0031962757 scopus 로고    scopus 로고
    • Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
    • Sieradzki K., Villari P., Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 1998, 42:100-107.
    • (1998) Antimicrob Agents Chemother , vol.42 , pp. 100-107
    • Sieradzki, K.1    Villari, P.2    Tomasz, A.3
  • 16
    • 20844461306 scopus 로고    scopus 로고
    • Identification and characterization of clinical isolates of members of the Staphylococcus sciuri group
    • Stepanovic S., Dakic I., Morrison D., Hauschild T., Jezek P., Petras P., et al. Identification and characterization of clinical isolates of members of the Staphylococcus sciuri group. J Clin Microbiol 2005, 43:956-958.
    • (2005) J Clin Microbiol , vol.43 , pp. 956-958
    • Stepanovic, S.1    Dakic, I.2    Morrison, D.3    Hauschild, T.4    Jezek, P.5    Petras, P.6
  • 17
    • 79951955637 scopus 로고    scopus 로고
    • Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin
    • Stuart J.I., John M.A., Milburn S., Diagre D., Wilson B., Hussain Z. Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin. Int J Antimicrob Agents 2011, 37:248-252.
    • (2011) Int J Antimicrob Agents , vol.37 , pp. 248-252
    • Stuart, J.I.1    John, M.A.2    Milburn, S.3    Diagre, D.4    Wilson, B.5    Hussain, Z.6
  • 18
    • 0035889577 scopus 로고    scopus 로고
    • Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study
    • Tacconelli E., Tumbarello M., Donati K.G., Bettio M., Spanu T., Leone F., et al. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin Infect Dis 2001, 33:1628-1635.
    • (2001) Clin Infect Dis , vol.33 , pp. 1628-1635
    • Tacconelli, E.1    Tumbarello, M.2    Donati, K.G.3    Bettio, M.4    Spanu, T.5    Leone, F.6
  • 19
    • 0036841516 scopus 로고    scopus 로고
    • Pathogenesis of infections due to coagulase-negative staphylococci
    • Von Eiff C., Peters G., Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002, 2:677-685.
    • (2002) Lancet Infect Dis , vol.2 , pp. 677-685
    • Von Eiff, C.1    Peters, G.2    Heilmann, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.